Keisuke Watanabe^1,2, Luo Yanping², Da Tong², Guedan Sonia^2,3, Ruella Marco^2,3, John Scholler², Keith Brian², Young Regina², Engels Boris⁴, Sorsa Suvi^5,6, Siurala Mikko^5,6, Tahtinen Siri^5,6, Hemminki Akseli^5,6,7, June Carl^2,3,8 (1.Department of Hematology, Nagoya University, Nagoya, Japan, 2.Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, 3.Parker Institute for Cancer Immunotherapy, University of Pennsylvania, 4.Dpt. Immuno-Oncology, Novartis Institutes for BioMedical Research, 5.Cancer Gene Therapy Group, University of Helsinki, 6.TILT Biotherapeutics Ltd, 7.Helsinki University Comprehensive Cancer Center, 8.Dpt. Pathology and Laboratory Medicine, University of Pennsylvania)

Satoru Aoyama^1,2, Shunichiro Yasuda^1,2, Daisuke Watanabe^1,2, Yoshihiro Umezawa², Osamu Miura², Norihiko Kawamata^1,2 (1.Department of Immunotherapy for Hematopoietic Disorders, Tokyo Medical and Dental University (TMDU), 2.Department of Hematology, Tokyo Medical and Dental University (TMDU))

Tatsuya Kamitori¹, Hidefumi Hiramatsu¹, Ryo Akazawa¹, Keiji Tasaka¹, Kiyotaka Isobe¹, Itaru Kato¹, Katsutsugu Umeda¹, Souichi Adachi², Junko Takita¹ (1.Dept. Pediatrics, Kyoto Univ., Kyoto, Japan, 2.Dept. Human Health Sciences, Kyoto Univ., Kyoto, Japan)

Reona Sakemura^1,2, Michelle J. Cox^1,2, Rosalie_M Sterner¹, Roman_H Khadka³, Nan Yang^1,5, Michael J. Hansen³, Fang Jin³, Kendall_J Schick^1,2, Mehrdad Hefazi^1,2, Michael_W Ruff^1,4, Neil_E Kay², Aaron_J Johnson³, Saad_S Kenderian^1,2,3 (1.T cell engineering laboratory, Mayo Clinic, Rochester, MN, United States of America, 2.Division of Hematology, Mayo Clinic, Rochester, MN, United States of America, 3.Department of Immunology, Mayo Clinic, Rochester, MN, United States of America, 4.Department of Neurology, Mayo Clinic, Rochester, MN, United States of America, 5.Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China)

Toru Uchiyama¹, Toshinao Kawai², Kazuhiko Nakabayashi³, Yukiko Ando¹, Yumi Akiba¹, Tomoko Minegishi¹, Nobuyuki Watanabe¹, Akane Miura¹, Toru Yasuda¹, Motohiro Kato⁴, Koji Kato⁵, Toyoki Nishimura⁶, Hiroyuki Nunoi⁶, Masafumi Onodera¹ (1.Dept. Human Genetics, NCCHD, Tokyo, Japan, 2.Div. Immunol., NCCHD, Tokyo, Japan, 3.Dept. Maternal-Fetal Biol., NCCHD, Tokyo Japan, 4.Child. Cancer Center, NCCHD, Tokyo, Japan, 5.Dept. Med. Biosys. Sci., Kyushu Univ., Fukuoka, Japan, 6.Div. Pediatr., Miyazaki Univ., Miyazaki, Japan)

Hirokazu Morokawa¹, Miyuki Tanaka¹, Shoji Saito¹, Hidemi Mochizuki², Akihito Shimoi², Shigeki Yagyu³, Yozo Nakazawa¹ (1.Shinshu University School of Medicine, Matsumoto, Japan, 2.Ina Research Inc., Ina, Japan, 3.Kyoto Prefectural University of Medicine, Kyoto, Japan)